[go: up one dir, main page]

DK0849990T3 - Populationer af hvilende celler til kerneoverføring - Google Patents

Populationer af hvilende celler til kerneoverføring

Info

Publication number
DK0849990T3
DK0849990T3 DK96928587T DK96928587T DK0849990T3 DK 0849990 T3 DK0849990 T3 DK 0849990T3 DK 96928587 T DK96928587 T DK 96928587T DK 96928587 T DK96928587 T DK 96928587T DK 0849990 T3 DK0849990 T3 DK 0849990T3
Authority
DK
Denmark
Prior art keywords
nuclear transfer
populations
resting cells
cell
quiescent
Prior art date
Application number
DK96928587T
Other languages
Danish (da)
English (en)
Inventor
Keith Henry Stockman Campbell
Ian Wilmut
Original Assignee
Roslin Inst Edinburgh
Mini Agriculture & Fisheries
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roslin Inst Edinburgh, Mini Agriculture & Fisheries, Biotech & Biolog Scien Res filed Critical Roslin Inst Edinburgh
Application granted granted Critical
Publication of DK0849990T3 publication Critical patent/DK0849990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8771—Bovine embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8773—Ovine embryos

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DK96928587T 1995-08-31 1996-08-30 Populationer af hvilende celler til kerneoverføring DK0849990T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517780.4A GB9517780D0 (en) 1995-08-31 1995-08-31 Biological manipulation
PCT/GB1996/002099 WO1997007669A1 (fr) 1995-08-31 1996-08-30 Populations de cellules quiescentes pour transfert de noyau

Publications (1)

Publication Number Publication Date
DK0849990T3 true DK0849990T3 (da) 2001-04-17

Family

ID=10779998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96928587T DK0849990T3 (da) 1995-08-31 1996-08-30 Populationer af hvilende celler til kerneoverføring

Country Status (23)

Country Link
US (5) US6147276A (fr)
EP (3) EP0930009A1 (fr)
JP (2) JP4081613B2 (fr)
KR (4) KR100533476B1 (fr)
CN (3) CN1230533C (fr)
AT (1) ATE199115T1 (fr)
AU (1) AU716956C (fr)
BR (1) BR9610034B1 (fr)
CA (1) CA2229568C (fr)
CZ (1) CZ60898A3 (fr)
DE (1) DE69611793T2 (fr)
DK (1) DK0849990T3 (fr)
ES (1) ES2155197T3 (fr)
GB (2) GB9517780D0 (fr)
HU (1) HUP9900234A3 (fr)
IL (1) IL123298A0 (fr)
NO (1) NO980845L (fr)
NZ (3) NZ337311A (fr)
PL (1) PL325331A1 (fr)
SG (1) SG75155A1 (fr)
SI (1) SI0849990T1 (fr)
WO (1) WO1997007669A1 (fr)
ZA (1) ZA967390B (fr)

Families Citing this family (227)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480772A (en) 1993-02-03 1996-01-02 Brandeis University In vitro activation of a nucleus
GB9517779D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US7332648B2 (en) 1995-08-31 2008-02-19 Roslin Institute Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US6077697A (en) 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US7696404B2 (en) 1996-08-19 2010-04-13 Advanced Cell Technology, Inc. Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
EP0941310A1 (fr) 1996-10-11 1999-09-15 THE TEXAS A&M UNIVERSITY SYSTEM Techniques permettant la production de cellules sexuelles primordiales et d'especes animales transgeniques
US20090092588A1 (en) * 1997-01-10 2009-04-09 University Of Massachusetts As Represented By Its Amherst Campus Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
US6235969B1 (en) * 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6215041B1 (en) * 1997-01-10 2001-04-10 University Of Mmassachusetts Cloning using donor nuclei from a non-quiesecent somatic cells
GB9703550D0 (en) * 1997-02-20 1997-04-09 Ppl Therapeutics Scotland Ltd Cell mediated transgenesis
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
DE69840439D1 (de) * 1997-04-24 2009-02-26 Univ Washington Zielgerichtete genveraenderung mit parvoviralen vektoren
US6921814B2 (en) 1997-06-19 2005-07-26 The General Hospital Corporation Torsin, torsin-related genes and methods of detecting neuronal disease
CA2294472C (fr) 1997-06-19 2010-06-15 The General Hospital Corporation Torsine, genes de torsine et leurs utilisations
JP2001509361A (ja) * 1997-07-03 2001-07-24 ユニヴァーシティー オヴ マサチューセッツ 分化した無血清飢餓細胞からの供与核を用いるクローニング
WO1999005266A2 (fr) * 1997-07-26 1999-02-04 Wisconsin Alumni Research Foundation Transfert de noyau entre des especes differentes
JP2001513336A (ja) * 1997-08-22 2001-09-04 ロスリン インスティチュート（エディンバラ） トランスジェニック動物の生産における「マリーナ」トランスポザンの使用
WO1999011776A1 (fr) * 1997-09-02 1999-03-11 Cancer Research Campaign Technology Limited Systeme de replication acellulaire et utilisations
AU1581899A (en) * 1997-10-28 1999-05-17 Biotransplant Incorporated Nuclear transfer for production of transgenic animal embryo
US6600087B1 (en) 1998-01-16 2003-07-29 Agrobiogen Gmbh Efficient nuclear transfer using fetal fibroblasts and multiple cloning procedures
US6331659B1 (en) 1998-01-21 2001-12-18 University Of Hawaii Cumulus cells as nuclear donors
WO1999046982A1 (fr) * 1998-03-16 1999-09-23 Relag Pty Ltd Transfert de noyau de cellules porcines
AUPP294898A0 (en) * 1998-04-15 1998-05-07 Monash University Method of nuclear transfer
GB9808325D0 (en) * 1998-04-20 1998-06-17 Ltr Ciz Di Associazione Italia Source of nuclei for nuclear transfer
GB9809178D0 (en) * 1998-04-29 1998-07-01 Univ Edinburgh Nuclear reprogramming of somatic cells
GB2365445A (en) 1998-10-12 2002-02-20 Geron Bio Med Ltd Porcine occcytes with improved developmental competence
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
EP1375654A3 (fr) * 1998-11-02 2008-01-16 GTC Biotherapeutics, Inc. Mammifères trangéniques et clonés
EP1127113A2 (fr) * 1998-11-02 2001-08-29 Genzyme Transgenics Corporation Mammiferes transgeniques et clones
US6580017B1 (en) 1998-11-02 2003-06-17 Genzyme Transgenics Corporation Methods of reconstructed goat embryo transfer
AU2003204830B2 (en) * 1998-11-02 2007-08-30 Gtc Biotherapeutics, Inc. Transgenic and cloned mammals
CA2351943A1 (fr) 1998-11-19 2000-06-02 Ppl Therapeutics (Scotland) Limited Stabilisation du lait provenant d'animaux transgeniques
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
WO2000042174A1 (fr) * 1999-01-13 2000-07-20 Ppl Therapeutics (Scotland) Limited Procede de double transfert de noyau et resultats de ce transfert
GB9903805D0 (en) * 1999-02-20 1999-04-14 Univ Sheffield Pluripotential cells-1
GB9903804D0 (en) * 1999-02-20 1999-04-14 Univ Sheffield Pluripotential cells-2
EP1179000A4 (fr) 1999-02-26 2005-10-12 Millennium Pharm Inc Proteines secretees et leurs utilisations
JP2002537785A (ja) 1999-03-04 2002-11-12 ピーピーエル セラピューティクス （スコットランド） リミテッド 体細胞の遺伝的改変とそれらの使用
US20020012660A1 (en) * 1999-03-04 2002-01-31 Alan Colman Method of preparing a somatic cells for nuclear transfer
JP2002542779A (ja) * 1999-04-28 2002-12-17 ユニヴェルシテ ドゥ モントリオール 核導入用の終期除核卵母細胞
AU4389699A (en) * 1999-06-04 2000-12-28 Istituto Zootecnico E Caseario Per La Sardegna Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby
EP1194570A1 (fr) 1999-06-23 2002-04-10 PPL Therapeutics (Scotland) Limited Proteines de fusion incorporant un lysozyme
BR0012099A (pt) * 1999-06-30 2003-07-29 Advanced Cell Tech Inc Transferência citoplásmica para de-diferenciar células recipientes
US7291714B1 (en) 1999-06-30 2007-11-06 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
JP3652308B2 (ja) * 1999-06-30 2005-05-25 ソウル ナショナル ユニバーシティー インダストリー ファウンデーション クローンウシの生産方法
JP2003503045A (ja) * 1999-06-30 2003-01-28 ワン，ウー−サク 異種間核移植技術を用いたクローントラの生産方法
EP1109890A4 (fr) * 1999-06-30 2004-12-29 Hwang Woo Suk Procede d'obtention d'embryons humains clones au moyen de techniques de transplantation inter-especes de noyaux
AU7072700A (en) 1999-08-23 2001-03-19 Dana-Farber Cancer Institute, Inc. Pd-1, a receptor for b7-4, and uses therefor
WO2002064799A2 (fr) 1999-09-28 2002-08-22 Transkaryotic Therapies, Inc. Arn messager optimise
EP2275559A3 (fr) 1999-09-28 2011-03-23 Shire Human Genetic Therapies, Inc. ARN messager (ARN-m) optimisé
KR20020038776A (ko) * 1999-09-30 2002-05-23 추후보정 클로닝된 트랜스게닉 포유동물의 제조 방법
AU1777301A (en) * 1999-11-19 2001-05-30 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
KR100417566B1 (ko) * 1999-11-19 2004-02-05 한국생명공학연구원 체세포 핵치환 복제수정란의 대량생산방법
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US6635802B1 (en) * 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
GB0001401D0 (en) * 2000-01-22 2000-03-08 Univ Edinburgh Methods for amplifying genetic material and use thereof
WO2001068831A2 (fr) 2000-03-15 2001-09-20 The University Of Georgia Research Foundation, Inc. Reprogrammation effective de materiel nucleaire chez des mammiferes
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
GB2360522A (en) 2000-03-24 2001-09-26 Geron Corp A strategy for maintaining pregnancy
WO2001088096A2 (fr) * 2000-05-15 2001-11-22 Geron Corporation Tissu animal pour xenotransplantation
NZ522844A (en) 2000-06-28 2005-02-25 Brigham & Womens Hospital PD-L2 molecules: novel PD-1 ligands and methods to identify compounds to modulate T cell activation
AU2001278204A1 (en) * 2000-08-01 2002-02-13 Xy Genetics, Llc Methods of selecting and cloning animals
AU2001284703B2 (en) 2000-08-03 2007-03-22 Therapeutic Human Polyclonals Inc. Production of humanized antibodies in transgenic animals
WO2002014473A2 (fr) 2000-08-15 2002-02-21 Board Of Trustees Of The University Of Illinois Animaux exprimant l'igf-i exogene dans leur lait
AU2001291558A1 (en) * 2000-09-06 2002-03-22 Nexia Biotechnologies, Inc. Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
US20040029825A1 (en) * 2001-10-03 2004-02-12 Davies Christopher J Methods of minimizing immunological rejection of a nuclear transfer fetus
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
CA2429722A1 (fr) 2000-11-28 2002-06-06 Wyeth Analyse de l'expression des acides nucleiques fkbp et polypeptides utiles dans le diagnostic et le traitement du cancer de la prostate
MXPA03004637A (es) 2000-11-28 2003-09-05 Wyeth Corp Analisis de expresion de acidos nucleicos y polipeptidos kiaa utiles en diagnostico y tratamiento de cancer de prostata.
AU2002232858B2 (en) 2000-12-22 2007-01-11 Sab, Llc Methods for cloning mammals using reprogrammed donor chromatin or donor cells
ATE466089T1 (de) 2000-12-22 2010-05-15 Agronomique Inst Nat Rech Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
US20020142397A1 (en) 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
EP1860199B1 (fr) 2001-01-12 2014-03-05 Exelixis, Inc. Modulation de signal de récépteur d'insuline
US20050177883A1 (en) 2001-01-30 2005-08-11 Rebholtz Paul C. Systems of transferring embryos and managing recipients
AU2002250020A1 (en) * 2001-02-02 2002-08-19 Erik Forsberg Method of cloning transgenic mammalian animals using pseudonuclei
DK1572862T3 (da) * 2001-02-20 2012-11-26 Intrexon Corp Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
CA2438832A1 (fr) 2001-02-23 2002-09-06 Elan Pharmaceuticals, Inc. Knockouts transgeniques de bace-1
JP2002262716A (ja) * 2001-03-07 2002-09-17 National Agricultural Research Organization 株化細胞を用いて家畜個体を作出する方法
WO2002072762A2 (fr) * 2001-03-08 2002-09-19 Advanced Cell Technology, Inc. Utilisation d'interference de l'arn pour produire des cellules souches de lignee specifique et d'autres cellules non differenciees, et production de cellules differenciees in vitro par coculture
AUPR363701A0 (en) 2001-03-09 2001-04-05 Garelag Pty Ltd Method for the production of nuclear transfer embryos
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
AU2002242854A1 (en) * 2001-03-21 2002-10-03 Geron Corporation Use of telomerase reverse transcriptase to create homozygous knockout animals
US7126039B2 (en) * 2001-03-21 2006-10-24 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
JP2004533226A (ja) 2001-04-02 2004-11-04 ワイス Ｂ７−４に対するｐｄ−１、ａレセプター、およびその使用
US20030027330A1 (en) * 2001-04-02 2003-02-06 Robert Lanza Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
US7384775B2 (en) 2001-04-16 2008-06-10 Wyeth Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US20030153044A1 (en) * 2001-05-14 2003-08-14 Monika Liljedahl Tissues or organs for use in xenotransplantation
US20030092174A1 (en) * 2001-05-14 2003-05-15 Monika Liljedahl Tissues or organs for use in xenotransplantation
AU2002326353A1 (en) * 2001-07-09 2003-01-29 Alexion Pharmaceuticals Inc. Cloned non-human mammals from contact inhibited donor cells
WO2003006477A1 (fr) 2001-07-12 2003-01-23 University Of Massachusetts Production in vivo of small interfering rnas that mediate gene silencing
EP1900815B1 (fr) 2001-07-12 2016-09-07 University of Massachusetts Production in vivo de petits ARN interférents qui modèrent le silençage génique
AU2002326483A1 (en) * 2001-07-31 2003-02-17 Simon Eric Aspland Genetically modified cows having reduced susceptibility to mad cow disease
US20030211603A1 (en) * 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
JP2005514921A (ja) 2001-11-09 2005-05-26 ダナ−ファーバー キャンサー インスティチュート インク ＰＧＣ−１β、新規ＰＧＣ−１相同体およびその用途
US20050170506A1 (en) * 2002-01-16 2005-08-04 Primegen Biotech Llc Therapeutic reprogramming, hybrid stem cells and maturation
US20050090004A1 (en) * 2003-01-16 2005-04-28 Sayre Chauncey B. Stem cell maturation for all tissue lines
US20030134422A1 (en) * 2002-01-16 2003-07-17 Sayre Chauncey Bigelow Stem cell maturation for all tissue lines
US8106255B2 (en) 2002-01-23 2012-01-31 Dana Carroll Targeted chromosomal mutagenasis using zinc finger nucleases
KR100502695B1 (ko) * 2002-02-28 2005-07-25 한국생명공학연구원 형질전환 효율이 향상된 복제수정란의 대량 생산 방법
US20030232410A1 (en) * 2002-03-21 2003-12-18 Monika Liljedahl Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
GB0207299D0 (en) * 2002-03-28 2002-05-08 Franks Christopher R Stem cell therapy
JP2005528095A (ja) * 2002-04-01 2005-09-22 ジーティーシー バイオセラピューティックス インコーポレイテッド 哺乳類種における核移植に使用するための細胞株を選択する方法
US20030207448A1 (en) * 2002-05-06 2003-11-06 Revera Gregory Henry Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
GB0211904D0 (en) * 2002-05-23 2002-07-03 Medical Res Council Nuclear transfer
US7410797B2 (en) * 2002-06-11 2008-08-12 Ogle Roy C Meningeal-derived stem cells
US7612250B2 (en) 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
US7361511B2 (en) 2002-08-20 2008-04-22 Millenium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2003298574B2 (en) * 2002-09-05 2008-04-24 California Institute Of Technology Use of chimeric nucleases to stimulate gene targeting
WO2004032877A2 (fr) 2002-10-10 2004-04-22 Wyeth Compositions, organismes et methodologies utilisant une nouvelle kinase humaine
US20040077077A1 (en) * 2002-10-18 2004-04-22 Xiangzhong Yang Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
US7208306B2 (en) 2002-10-24 2007-04-24 Wyeth Compositions employing a novel human protein phosphatase
NZ539459A (en) 2002-11-08 2009-02-28 Kirin Pharma Kk Transgenic ungulates having reduced prion protein activity and uses thereof
EP1588142A4 (fr) 2002-11-21 2007-10-31 Wyeth Corp Methodes de diagnostic de rcc et autres tumeurs solides
US7297525B2 (en) 2002-11-27 2007-11-20 Wyeth Composition employing a novel human kinase
JP2006508676A (ja) * 2002-12-10 2006-03-16 ジーティーシー バイオセラピューティックス インコーポレイテッド 追加の核移植のための細胞ドナーとして体細胞核移植胚を利用する方法および系
JP5479663B2 (ja) 2002-12-20 2014-04-23 セレラ コーポレーション 心筋梗塞に関連する遺伝的多型、その検出方法および使用
EP1998177A3 (fr) 2003-01-06 2009-02-18 Wyeth Compositions et procédés de diagnostic et de traitement des cancers du colon
FR2855183B1 (fr) 2003-05-23 2005-08-12 Agronomique Inst Nat Rech Procede de clonage du rat par transfert nucleaire
CA2528012C (fr) 2003-06-02 2015-11-24 University Of Massachusetts Procedes et compositions de commande de l'efficacite permettant de rendre silencieux un arn
ES2357116T5 (es) 2003-06-02 2021-09-03 Univ Massachusetts Métodos y composiciones para mejorar la eficacia y especificad de FNAi
US7888121B2 (en) * 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US20120196370A1 (en) 2010-12-03 2012-08-02 Fyodor Urnov Methods and compositions for targeted genomic deletion
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
JP2007502118A (ja) 2003-08-14 2007-02-08 エクセリクシス， インク． βカテニン経路のモディファイヤーとしてのＳＵＬＦｓ及び使用方法
CA2761987A1 (fr) 2003-10-07 2005-04-21 Millennium Pharmaceuticals, Inc. Molecules d'acides nucleiques et proteines pour l'identification, l'evaluation, la prevention et le traitement du cancer de l'ovaire
EP1681988B1 (fr) 2003-11-12 2015-04-08 The Children's Hospital Medical Center Procede de diagnostic et de traitement de troubles pulmonaires
CA3048093A1 (fr) 2003-11-26 2005-06-23 Celera Corporation Polymorphismes nucleotides simples associes a des troubles cardiovasculaires et a une reponse au medicament, leurs procedes de detection et d'utilisation
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
AU2005237494B2 (en) 2004-04-22 2010-06-10 Kyowa Hakko Kirin Co., Ltd Transgenic animals and uses thereof
JP5236286B2 (ja) 2004-05-07 2013-07-17 セレラ コーポレーション 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2006081542A (ja) * 2004-08-18 2006-03-30 Institute Of Physical & Chemical Research クローン哺乳動物の作成方法
US8889639B2 (en) 2004-10-22 2014-11-18 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
CN1274829C (zh) 2004-12-10 2006-09-13 四川大学华西医院 抗eb病毒所致肿瘤多肽及其应用与制备方法
JP5590697B2 (ja) 2005-03-11 2014-09-17 セレラ コーポレーション 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
US20060286666A1 (en) * 2005-06-17 2006-12-21 Kang Ji Y Methods and apparatuses for culturing stem cell using biomaterial shell
WO2007052096A2 (fr) * 2005-06-29 2007-05-10 Cameron Malcolm Lang Clokie Production de proteines morphogeniques osseuses dans des mammiferes transgeniques
KR100733012B1 (ko) 2005-07-26 2007-06-28 재단법인서울대학교산학협력재단 복제된 개과 동물 및 이의 생산 방법
US20090186097A1 (en) 2005-08-09 2009-07-23 David Lee Ayares Transgenic Ungulates Expressing CTLA4-IG and Uses Thereof
WO2007030820A2 (fr) 2005-09-09 2007-03-15 The Johns Hopkins University Manipulation de cellules t regulatrices et de fonctions dc en ciblant des genes de neuritine a l'aide d'agonistes et d'antagonistes d'anticorps
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7695911B2 (en) 2005-10-26 2010-04-13 Celera Corporation Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
US8173860B2 (en) 2006-04-21 2012-05-08 Gtc Biotherapeutics, Inc. Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
CN102719444B (zh) 2006-09-01 2016-12-14 人类多细胞株治疗学公司 人或人源化免疫球蛋白在非人转基因动物中增强的表达
WO2008033239A2 (fr) 2006-09-11 2008-03-20 Applera Polymorphismes genetiques lies au psoriasis, methodes de detection et utilisations associees
CA2915679C (fr) 2006-10-20 2017-12-12 Celera Corporation Polymorphismes genetiques associes a la thrombose veineuse, procedes pour les detecter et utilisations
KR101398220B1 (ko) * 2006-10-30 2014-05-22 건국대학교 산학협력단 형질전환 배아 생성방법
WO2008085891A1 (fr) * 2007-01-05 2008-07-17 Worcester Polytechnic Institute Amélioration du clonage de cellules somatiques grâce à des facteurs associés au fuseau des ovocytes
KR100829426B1 (ko) 2007-01-17 2008-05-15 재단법인서울대학교산학협력재단 복제개의 생산 방법
US20080222745A1 (en) * 2007-03-07 2008-09-11 Utah State University Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
KR100868245B1 (ko) 2007-05-29 2008-11-11 강원대학교산학협력단 데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
WO2009055656A2 (fr) 2007-10-26 2009-04-30 Centocor, Inc. Vecteurs, cellules hôtes, procédés de production et utilisations
US8039212B2 (en) 2007-11-05 2011-10-18 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
JP2011508600A (ja) 2008-01-04 2011-03-17 ソウル ナショナル ユニバーシティ インダストリー ファウンデーション 形質転換された複製犬の生産方法
US20090221620A1 (en) 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
US20110071049A1 (en) 2008-03-12 2011-03-24 Nathaniel Heintz Methods and compositions for translational profiling and molecular phenotyping
US8288094B2 (en) 2008-04-09 2012-10-16 Institut Pasteur APOBEC3 mediated DNA editing
EP3225252A1 (fr) 2008-05-02 2017-10-04 Laboratoire Français du Fractionnement et des Biotechnologies Traitement de saignement par un fibrinogène de faible demi-vie
EP2295538B1 (fr) * 2008-07-07 2015-10-21 Takara Bio Inc. Méthode de production d une cellule souche pluripotente
EP2310525B1 (fr) 2008-07-09 2014-02-26 Celera Corporation Polymorphismes génétiques associés à des maladies cardiovasculaires et procédés de détection et d'utilisation de ceux-ci
WO2010080985A1 (fr) 2009-01-08 2010-07-15 Dana-Farber Cancer Institute, Inc. Compositions et procédés pour induire la différenciation du tissu adipeux brun
US8722964B2 (en) 2009-04-23 2014-05-13 Transposagen Biopharmaceuticals, Inc. Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
EP2267153A1 (fr) 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification de la mutation du gène unc5c du récepteur de la nétrine-1 dans des cancers solides
WO2011002988A1 (fr) 2009-07-01 2011-01-06 Transposagen Biopharmaceuticals, Inc. Modèles de rats génétiquement modifiés pour l'immunodéficience combinée sévère
EP2456876A2 (fr) 2009-07-24 2012-05-30 Transposagen Biopharmaceuticals, Inc. Modèles rats génétiquement modifiös pour les voies de signalisation cytokine-cytokine
US20110145936A1 (en) 2009-07-30 2011-06-16 Ostertag Eric M Genetically Modified Rat Models for Pharmacokinetics
EP2461672A2 (fr) 2009-08-05 2012-06-13 Transposagen Biopharmaceuticals, Inc. Modèles de rats génétiquement modifiés pour le métabolisme de médicaments
EP2467013A2 (fr) 2009-08-20 2012-06-27 Transposagen Biopharmaceuticals, Inc. Modèles de rat génétiquement modifié pour l'analyse de la douleur
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
CA2787685A1 (fr) 2010-01-22 2011-07-28 Dana-Farber Cancer Institute, Inc. Compositions, kits, et procedes d'identification, d'evaluation, de prevention, et de therapie de troubles metaboliques
TWI518325B (zh) 2010-02-04 2016-01-21 自治醫科大學 對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
NZ737844A (en) 2010-03-26 2022-09-30 Dartmouth College Vista regulatory t cell mediator protein, vista binding agents and use thereof
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US8383793B2 (en) 2010-04-15 2013-02-26 St. Jude Children's Research Hospital Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
US20110269735A1 (en) 2010-04-19 2011-11-03 Celera Corporation Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
US8956865B2 (en) 2010-08-11 2015-02-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of growing an embryo to a blastocyst stage of development
US20120108651A1 (en) 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
WO2012071393A2 (fr) 2010-11-23 2012-05-31 The New York Stem Cell Foundation Procédé de production de cellules souches pluripotentes
NZ759163A (en) 2011-02-14 2023-03-31 Revivicor Inc Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
WO2012129198A1 (fr) 2011-03-23 2012-09-27 Transposagen Biopharmaceuticals, Inc. Modèles de rat génétiquement modifiés pour l'étude de l'obésité et du diabète
DK2709445T3 (en) 2011-05-16 2018-11-19 Univ Missouri ANIMALS RESISTANT TO PORCIN REPRODUCTION AND RESPIRATION DISEASE
US8969519B2 (en) 2011-09-13 2015-03-03 Dana-Farber Cancer Institute, Inc. Compositions and methods for brown fat induction and activity using FNDC5
CN102391989A (zh) * 2011-10-12 2012-03-28 扬州大学 转基因动物重组产物精确分析检验方法
WO2013120554A1 (fr) 2012-02-15 2013-08-22 Novo Nordisk A/S Anticorps qui se lient à la protéine 1 de reconnaissance de peptidoglycane
LT2814844T (lt) 2012-02-15 2017-10-25 Novo Nordisk A/S Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
BR112014032276A2 (pt) 2012-06-22 2017-11-28 King S College London construtos de vista-ig e o uso de vista-ig para o tratamento de distúrbios autoimunes, alérgicos e inflamatórios
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
CN109793893B (zh) 2012-09-07 2023-05-26 达特茅斯大学理事会 用于诊断和治疗癌症的vista调节剂
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
KR20160002713A (ko) 2013-02-13 2016-01-08 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
CN105263319A (zh) 2013-02-13 2016-01-20 法国化学与生物科技实验室 具有经修饰的糖基化的蛋白及其生产方法
ES2703056T3 (es) 2013-04-30 2019-03-06 Univ Konkuk Ind Coop Corp Vector de direccionamiento de CMP-ácido acetilneuramínico hidroxilasa, animal transgénico para xenotrasplante introducido con el vector, y método de fabricación del mismo
IL301714A (en) 2013-12-24 2023-05-01 Janssen Pharmaceutica Nv Antibodies and anti-VISTA fragments
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
EP3094736A4 (fr) 2014-01-14 2017-10-25 Dana-Farber Cancer Institute, Inc. Compositions et méthodes pour l'identification, l'évaluation, la prévention, et le traitement d'un mélanome à l'aide d'isoformes de pd-l1
WO2015191881A2 (fr) 2014-06-11 2015-12-17 Green Kathy A Utilisation d'antagonistes et d'agonistes vista pour supprimer ou améliorer l'immunité humorale
CN113214397A (zh) 2014-07-17 2021-08-06 诺和诺德股份有限公司 定点诱变trem-1抗体以降低黏度
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
EP3226900A4 (fr) 2014-12-05 2018-09-19 Immunext, Inc. Identification de vsig8 en tant que récepteur putatif de vista et son utilisation pour produire des modulateurs de vista/vsig8
HUE052606T2 (hu) 2014-12-09 2021-05-28 Regeneron Pharma Humanizált differenciációs klaszter 274 génnel rendelkezõ nem humán állatok
CN104823921A (zh) * 2015-05-21 2015-08-12 蒙汉勤 一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
EP3722314A1 (fr) 2015-06-24 2020-10-14 Janssen Pharmaceutica NV Anticorps anti-vista et fragments
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
CN109475107A (zh) 2015-08-06 2019-03-15 密苏里大学管理者 具有修饰的cd163基因的抗病原体动物
CA3002676A1 (fr) 2015-10-29 2017-05-04 Dana-Farber Cancer Institute, Inc. Procedes pour identifier, evaluer, prevenir et traiter des troubles metaboliques au moyen de pm20d1 et d'acides amines n-lipides
MX2018009800A (es) 2016-02-12 2018-11-09 Janssen Pharmaceutica Nv Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
KR20250153855A (ko) 2016-04-15 2025-10-27 이뮤넥스트, 인크. 항-인간 vista 항체 및 이의 용도
MA49651A (fr) 2017-07-19 2021-04-28 Childrens Medical Center Compositions et procédés pour traiter des maladies associées à un défaut d'empreinte
MY206833A (en) 2018-04-02 2025-01-09 Bristol Myers Squibb Co Anti-trem-1 antibodies and uses thereof
KR20200141470A (ko) 2018-04-06 2020-12-18 칠드런'즈 메디컬 센터 코포레이션 체세포 재프로그래밍 및 각인의 조정을 위한 조성물 및 방법
US11160260B2 (en) 2018-04-17 2021-11-02 The Curators Of The University Of Missouri Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
US11548938B2 (en) 2018-08-21 2023-01-10 Quidel Corporation DbpA antibodies and uses thereof
WO2021127547A2 (fr) 2019-12-19 2021-06-24 Quidel Corporation Fusion d'anticorps monoclonaux
KR20230107335A (ko) 2020-11-20 2023-07-14 레비비코르 인코포레이션 이종이식을 위한 성장 호르몬 수용체 녹아웃을 갖는 다중-전이유전자 돼지
EP4404740A1 (fr) 2021-09-20 2024-07-31 Revivicor Inc. Porcs multitransgéniques comprenant dix modifications génétiques pour la xénotransplantation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890003947B1 (ko) * 1985-12-11 1989-10-13 가부시기가이샤 시마즈세이사구쇼 세포융합장치
US5057420A (en) * 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
GB8714426D0 (en) * 1987-06-19 1987-07-22 Agricultural & Food Res Culture technique
CA2059199A1 (fr) * 1992-01-10 1993-07-11 Steen Willadsen Methode d'obtention d'oeufs de mammiferes, reconstitues et a maturite, par transplantation du noyau
GB2265909B (en) * 1992-04-01 1996-03-20 Inst Of Animal Physiology And Fusion of donor nucleus with recipient cytoplast in the absence of calcium ion
WO1994006422A1 (fr) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Utilisation de taxol pour traiter des lymphomes et des cancers du sein
CA2092258A1 (fr) * 1992-12-30 1994-07-01 Steven L. Stice Cellules de donneur synchronisees pour le transfert de noyaux chez les bovins
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
ES2210258T5 (es) * 1993-07-29 2009-01-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Procedimiento de tratamiento de la ateroesclerosis o reestenosis usando un agente estabilizante de microtubulos.
WO1995016770A1 (fr) * 1993-12-17 1995-06-22 Abs Global, Inc. Cellules souches embryonnaires derivees de cellules du stade preblastocyste d'ongule et leur utilisation pour produire des ongules chimeres et transgeniques clones
EP0739412B1 (fr) * 1993-12-23 2002-02-27 Infigen, Inc. CELLULES d'ongules, SOUCHES D'EMBRYONS UTILISEES COMME DONNEUSES DE NOYAUX ET PROCEDES DE TRANSFERT DE NOYAUX POUR LA PRODUCTION D'ANIMAUX CHIMERIQUES ET TRANSGENIQUES
GB9417831D0 (en) * 1994-09-05 1994-10-26 Biotech & Biolog Scien Res Biological manipulation
US7332648B2 (en) 1995-08-31 2008-02-19 Roslin Institute Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US6215041B1 (en) 1997-01-10 2001-04-10 University Of Mmassachusetts Cloning using donor nuclei from a non-quiesecent somatic cells
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6235969B1 (en) 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
WO1999005266A2 (fr) * 1997-07-26 1999-02-04 Wisconsin Alumni Research Foundation Transfert de noyau entre des especes differentes
US6225243B1 (en) * 1998-08-03 2001-05-01 Bba Nonwovens Simpsonville, Inc. Elastic nonwoven fabric prepared from bi-component filaments
GB2365445A (en) * 1998-10-12 2002-02-20 Geron Bio Med Ltd Porcine occcytes with improved developmental competence
US20050156424A1 (en) * 2000-02-29 2005-07-21 Thyssenkrupp Presta Ag Steering column and manufacturing method thereof

Also Published As

Publication number Publication date
BR9610034A (pt) 1999-12-21
KR20060053008A (ko) 2006-05-19
CN1769431A (zh) 2006-05-10
GB9802915D0 (en) 1998-04-08
JP2000506722A (ja) 2000-06-06
GB2318578A (en) 1998-04-29
ATE199115T1 (de) 2001-02-15
AU6831096A (en) 1997-03-19
KR20070047848A (ko) 2007-05-07
HUP9900234A2 (hu) 1999-05-28
HUP9900234A3 (en) 2000-03-28
BR9610034B1 (pt) 2011-03-09
CN1769432A (zh) 2006-05-10
EP0930009A1 (fr) 1999-07-21
CA2229568C (fr) 2011-11-22
KR19990044148A (ko) 1999-06-25
ZA967390B (en) 1998-03-02
IL123298A0 (en) 1998-09-24
AU716956C (en) 2002-03-28
DE69611793T2 (de) 2001-09-20
WO1997007669A1 (fr) 1997-03-06
KR100793220B1 (ko) 2008-01-10
US20070028313A1 (en) 2007-02-01
NO980845L (no) 1998-04-29
SG75155A1 (en) 2000-09-19
CN1202084A (zh) 1998-12-16
ES2155197T3 (es) 2001-05-01
US20060156424A1 (en) 2006-07-13
CN1230533C (zh) 2005-12-07
NO980845D0 (no) 1998-02-27
KR20050088163A (ko) 2005-09-01
EP0849990A1 (fr) 1998-07-01
EP0849990B1 (fr) 2001-02-14
US20050010966A1 (en) 2005-01-13
JP2006217913A (ja) 2006-08-24
AU716956B2 (en) 2000-03-09
EP1005789A2 (fr) 2000-06-07
CN100422317C (zh) 2008-10-01
PL325331A1 (en) 1998-07-20
HK1004938A1 (en) 1998-12-18
SI0849990T1 (en) 2001-06-30
GB9517780D0 (en) 1995-11-01
US20070033664A1 (en) 2007-02-08
US6147276A (en) 2000-11-14
CZ60898A3 (cs) 1998-07-15
JP4081613B2 (ja) 2008-04-30
NZ316149A (en) 1999-10-28
US7355094B2 (en) 2008-04-08
US7514258B2 (en) 2009-04-07
NZ334288A (en) 2000-06-23
DE69611793D1 (de) 2001-03-22
GB2318578B (en) 2000-01-19
KR100533476B1 (ko) 2006-04-21
CA2229568A1 (fr) 1997-03-06
NZ337311A (en) 2008-05-30
HK1090089A1 (zh) 2006-12-15
EP1005789A3 (fr) 2005-03-02
US7232938B2 (en) 2007-06-19

Similar Documents

Publication Publication Date Title
DK0849990T3 (da) Populationer af hvilende celler til kerneoverføring
IL100040A0 (en) Nucleic acid amplification by two-enzyme,self-sustained sequence replication
FI881127L (fi) Slityta pao ett radialdaeck, vars ytmoenster aer foersett med inskaerningar med en brott- eller vaoglinjeprofil i djupriktning.
NO912473L (no) Tynn, roerformet, selvbaerende elektrode for elektrokjemiske celler.
DE69019009D1 (de) Zellkulturverfahren.
NO960547D0 (no) Biokompatible immunoisolatoriske kapsler inneholdende genetisk endrede celler
DK0474382T3 (da) Elektrokemiske celler, som hovedsgelig er fri for kviksølv
DK27087D0 (da) Genoprettelse af tilretning, dvs. framing i et kommunikationssystem
EP0773993A4 (fr) Cellules porcines traitees par genie genetique
FI922409A7 (fi) Menetelmä soluviljelyä varten
GB2331751B (en) Quiescent cell populations for nuclear transfer
GB2207710B (en) Method for harnessing tidal energy.
NO974239D0 (no) Sertolli celler som transplantasjons hjelpemiddel for celle transplantasjon
JPS56168059A (en) System for power generation and collecting heat by solar beams
AU9072982A (en) Photosensitive element, photovoltaic cell, and method of preparing the element
FI880681A7 (fi) Menetelmä perunan lisääntymistehokkuuden kohottamiseksi in vitro.
ES8600388A1 (es) Procedimiento para la fusion celular de ovas o algas comestibles
IT8819413A0 (it) Sistema elettronico di controllo per cella di lievitazione.
DZ1948A1 (fr) Système de récupération et d'alimentation énergétique, système hydro-électrique.
NO951429L (no) Transportpontonger
KR970025893U (ko) 니켈-수소 전지의 음극 집전체
YU67083A (en) Device for carrying out a method of combusting of waste parts of corn,particularly straw
DK151272C (da) Fremgangsmaade til immobilisering af glucoseisomeraseaktive mikroorganismer.
NO163606C (no) Kameraholder for montering i et fly for, fastholding av spesialkamera.
GB9809010D0 (en) Recovery of cryopreserved plant cells